Pregabalin in neuropathic pain: a more "pharmaceutically elegant" gabapentin?

D. Guay

DOI: https://doi.org/10.1016/J.AMJOPHARM.2005.12.008

2005-12-01

The American Journal of Geriatric Pharmacotherapy

Abstract:

What problem does this paper attempt to address?

Intensity-modulated radiotherapy of nasopharyngeal carcinoma: a comparative treatment planning study of photons and protons

Zahra Taheri-Kadkhoda,Thomas Björk-Eriksson,Simeon Nill,Jan J Wilkens,Uwe Oelfke,Karl-Axel Johansson,Peter E Huber,Marc W Münter

DOI: https://doi.org/10.1186/1748-717X-3-4

2008-01-24

Abstract:Background: The aim of this treatment planning study was to investigate the potential advantages of intensity-modulated (IM) proton therapy (IMPT) compared with IM photon therapy (IMRT) in nasopharyngeal carcinoma (NPC). Methods: Eight NPC patients were chosen. The dose prescriptions in cobalt Gray equivalent (GyE) for gross tumor volumes of the primary tumor (GTV-T), planning target volumes of GTV-T and metastatic (PTV-TN) and elective (PTV-N) lymph node stations were 72.6 GyE, 66 GyE, and 52.8 GyE, respectively. For each patient, nine coplanar fields IMRT with step-and-shoot technique and 3D spot-scanned three coplanar fields IMPT plans were prepared. Both modalities were planned in 33 fractions to be delivered with a simultaneous integrated boost technique. All plans were prepared and optimized by using the research version of the inverse treatment planning system KonRad (DKFZ, Heidelberg). Results: Both treatment techniques were equal in terms of averaged mean dose to target volumes. IMPT plans significantly improved the tumor coverage and conformation (P < 0.05) and they reduced the averaged mean dose to several organs at risk (OARs) by a factor of 2-3. The low-to-medium dose volumes (0.33-13.2 GyE) were more than doubled by IMRT plans. Conclusion: In radiotherapy of NPC patients, three-field IMPT has greater potential than nine-field IMRT with respect to tumor coverage and reduction of the integral dose to OARs and non-specific normal tissues. The practicality of IMPT in NPC deserves further exploration when this technique becomes available on wider clinical scale.
Dosimetric Evaluation of Hippocampus Sparing Intensity Modulated Radiation Therapy in Patients with Stage T1-T2 and Stage T3-T4 Nasopharyngeal Carcinoma

Xiaofeng Zhou,Kui Wu,Niharika Prasad,Sanjay Jaiswal,Biao Jiang,Xia Li,Wenzheng Sun,Lingli Mao,Kanghua Huang,Minghan Shi,Shen Li,Qichun Wei

DOI: https://doi.org/10.1016/j.adro.2024.101646

2024-01-01

Advances in Radiation Oncology

Abstract:Purpose: To compare the hippocampus (HPC) dose reduced by HPC-sparing intensity modulated radiation therapy (IMRT) plans between nasopharyngeal carcinoma (NPC) patients of stages T1-T2 and T3-T4, and to investigate the correlation between the dose of the HPC and the volume of PTVnx70 (the planning target volume of the primary tumor in the nasopharynx that received 70 Gy). Methods and Materials: Fifty-eight NPC patients were retrospectively evaluated. HPC-nonsparing IMRT or sparing IMRT for each patient was designed according to the protocol for NPC. Dose-volume histogram was used to evaluate the IMRT plans for each patient. The difference in values of HPC parameters (eg, D-min[NS] - D-min[S]) between HPC-sparing and nonsparing plans in the stage T1-T2 group and stage T3-T4 group were compared. The correlations between the dose of the HPC and the volume of PTVnx70 were analyzed. Results: There was no significance between HPC-sparing and nonsparing IMRT plans. Compared with the HPC-nonsparing plans, the HPC-sparing plans significantly decreased both dosimetric and volumetric parameters for the HPC (P < .05), except for D-min, D-98%,D- and V-5. The medians of D-median[NS] - D-median[S], D-mean[NS] - D-mean[S], D-40%[NS] - D-40%[S], V-30[NS] - V-30[S], V-40[NS] - V-40[S] and V-50[NS] - V-50[S] in the T1-T2 group were significantly lower than in the T3-T4 group (P < .05), respectively. Both dosimetric and volumetric parameters for the HPC were positively correlated with the volume of PTVnx70 in HPC-sparing and HPC-nonsparing plans (P < .05). The volume of PTVnx70 was positively correlated with D-median[NS] - D-median[S], D-mean[NS] - D-mean[S], D-40%[NS] - D-40%[S], V-40[NS] - V-40[S] and V-50[NS] - V-50[S] (P < .05). Conclusions: HPC-sparing IMRT plans may play a more significant role in decreasing D-median, D-mean, D-40%,D- and V-30-V-50 of HPC in NPC patients with stages T3-T4 than those in stages T1-T2. PTVnx70 volume of NPC patients is positively correlated with all dosimetric and volumetric parameters of HPC and the reduction of specific dosage parameters by HPC-sparing IMRT plans. (c) 2024 Published by Elsevier Inc. on behalf of American Society for Radiation Oncology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Dosimetric comparison of intensity modulated radiotherapy and intensity modulated proton therapy in the treatment of recurrent nasopharyngeal carcinoma

Hing Ming Hung,Oliver Cheuk Ming Chan,Chi Hang Mak,Wai Man Hung,Wai Tong Ng,Michael Chi Hang Lee

DOI: https://doi.org/10.1016/j.meddos.2021.07.002

Abstract:Background and purpose: To compare the dosimetric performance of Intensity Modulated Proton Therapy (IMPT) and Intensity Modulated Radiotherapy (IMRT) in terms of target volume coverage and sparing of neurological organs-at-risk (OARs) in salvaging recurrent nasopharyngeal carcinoma (rNPC). The maximum dose to the internal carotid artery (ICA) and nasopharyngeal (NP) mucosa, which are associated with potential carotid blowout and massive epistaxis, were also evaluated. Materials and methods: IMRT and IMPT treatment plans were created for twenty patients with locally advanced rNPC. Planning Target Volume (PTV) was used to account for the setup and spatial error/uncertainty in the IMRT planning. Robust optimization on Clinical Target Volume (CTV) coverage with consideration of range and setup uncertainty was employed to produce two IMPT plans with 3-field and 4-field arrangements. The planning objective was to deliver 60 Gy to the PTV (IMRT) and CTV (IMPT) without exceeding the maximum lifetime cumulative Biologically Effective Dose (BED) of the neurological OARs (applied to the Planning organs-at-risk volume). The target dose coverage as well as the maximum dose to the neurological OARs, ICA, and NP mucosa were compared. Results: Compared with IMRT, 3-field IMPT achieved better coverage to GTV V100% (83.3% vs. 73.2%, P <0.01) and CTV V100% (80.5% vs. 72.4%, P <0.01), and lower maximum dose to the critical OARs including the spinal cord (19.2 Gy vs. 22.3 Gy, P <0.01), brainstem (30.0 Gy vs. 32.3 Gy, P <0.01) and optic chiasm (6.6 Gy vs. 9.8 Gy, P <0.01). The additional beam with the 4-fields IMPT plans further improved the target coverage from the 3-field IMPT (CTV V98%: 85.3% vs. 82.4%, P <0.01) with similar OAR sparing. However, the target dose was highly non-uniform with both IMPT plans, leading to a significantly higher maximum dose to the ICA (∼68 Gy vs. 62.6 Gy, P <0.01) and NP mucosa (∼72 Gy vs. 62.8 Gy, P <0.01) than IMRT. Conclusion: IMPT demonstrated some dosimetric advantage over IMRT in treating rNPC. However, IMPT could also result in very high dose hot spots in the target volume. Careful consideration of the ICA and NP mucosal complications is recommended when applying IMPT on rNPC patients.
[Interhemispheric extracranial and intracranial tumor of parietal area (chondromyxoid fibroma) in a 13-year-old child with 7 years of follow-up].

A. Iwaniukowicz,P. Kowiański

1996-09-01

Neurologia i Neurochirurgia Polska

Abstract:A case of extra-intracranial, parietal chondromyxoid fibroma in a 13-year old girl operated successfully and followed by 7-years observation is presented. Apart from infrequent occurrence of the tumour diagnostic difficulties due to atypical cranial location are emphasized.
Robust optimization incorporating weekly predicted anatomtical CTs in IMPT of nasopharyngeal cancer

Mark Ka Heng Chan,Ying Zhang

DOI: https://doi.org/10.1088/1361-6560/ad8859

IF: 3.5

2024-10-18

Physics in Medicine and Biology

Abstract:Objective: This study proposes a robust optimization (RO) strategy utilizing virtual CTs (vCTs) predicted by an anatomical model in intensity–modulated proton therapy (IMPT) for nasopharyngeal cancer (NPC). Methods and Materials: For ten NPC patients, vCTs capturing anatomical changes at different treatment weeks were generated using a population average anatomy model. Two robust optimization strategies of a 6 beams IMPT with 3mm setup uncertainty (SU) and 3% range uncertainty (RU) were compared: conventional robust optimization (cRO) based on a single planning CT (pCT), and anatomical robust optimization incorporating 2 and 3 predicted anatomies (aRO2 and aRO3). The robustness of these plans was assessed by recalculating them on weekly CTs (week 2 to 7) and extracting the voxel wise–minimum and maximum doses 1mm SU and 3% RU (voxmin–\max1mm3%). Results: The aRO plans demonstrated improved robustness in CTV1&2 coverage compared to cRO plans. The weekly evaluation showed a lower plan adaptation rate for aRO3 (40%) vs. cRO (70%), The weekly nominal and voxmax1mm3% doses to OARs, especially spinal cord, are better controlled relative to their baseline doses at week 1 with aRO plans. The accumulated dose analysis showed that CTV1&2 had adequate coverage and serial organs (spinal cord and brainstem) were within their dose tolerances in the voxmin–\max1mm3%, respectively. Conclusion: Incorporating predicted weekly CTs from a population based average anatomy model in RO improves week–to–week target dose coverage and reduces false plan adaptations without increasing normal tissue doses. This approach enhances IMPT plan robustness, potentially facilitating reduced setup uncertainty and further lowering OAR doses.

engineering, biomedical,radiology, nuclear medicine & medical imaging
Potential effect of robust and simple IMRT approach for left-sided breast cancer on cardiac mortality.

F. Lohr,M. El-Haddad,B. Dobler,Roland Grau,H. Wertz,U. Kraus-Tiefenbacher,V. Steil,Y. Madyan,F. Wenz

DOI: https://doi.org/10.1016/j.ijrobp.2008.07.018

2009-05-01

Abstract:
Aortocaval fistula associated with ruptured abdominal aortic aneurysm.

S. Nakazawa,J. Mohara,Toru Takahashi,N. Koike,I. Takeyoshi

DOI: https://doi.org/10.1016/j.avsg.2014.03.015

IF: 1.5

2014-10-01

Annals of Vascular Surgery

Abstract:
Dosimetric Comparison and Selection Criteria of Intensity-Modulated Proton Therapy and Intensity-Modulated Radiation Therapy for Adaptive Re-Plan in T3-4 Nasopharynx Cancer Patients

Mincheol Ko,Kyungmi Yang,Yong Chan Ahn,Sang Gyu Ju,Dongryul Oh,Yeong-bi Kim,Dong Yeol Kwon,Seyjoon Park,Kisung Lee

DOI: https://doi.org/10.3390/cancers16193402

2024-10-06

Cancers

Abstract:Background: Proton therapy requires caution when treating patients with targets near neural structures. Intuitive and quantitative guidelines are needed to support decision-making concerning the treatment modality. This study compared dosimetric profiles of intensity-modulated proton therapy (IMPT) and intensity-modulated radiation therapy (IMRT) using helical tomotherapy (HT) for adaptive re-planning in cT3-4 nasopharyngeal cancer (NPCa) patients, aiming to establish criteria for selecting appropriate treatment modalities. Methods: HT and IMPT plans were generated for 28 cT3-4 NPCa patients undergoing definitive radiotherapy. Dosimetric comparisons were performed for target coverage and high-priority organs at risk (OARs). The correlation between dosimetric parameters and RT modality selection was analyzed with the target OAR distances. Results: Target coverages were similar, while IMPT achieved better dose spillage. HT was more favorable for brainstem D1, optic chiasm Dmax, optic nerves Dmax, and p-cord D1. IMPT showed advantages for oral cavity Dmean. Actually, 14 IMPT and 14 HT plans were selected as adaptive plans, with IMPT allocated to most cT3 patients (92.9% vs 42.9%, p = 0.013). The shortest distances from the target to neural structures were negatively correlated with OAR doses. Receiver operating characteristic curve analyses were carried out to discover the optimal cut-off values of the shortest distances between the target and the OARs (temporal lobes and brainstem), which were 0.75 cm (AUC = 0.908, specificity = 1.00) and 0.85 cm (AUC = 0.857, specificity = 0.929), respectively. Conclusions: NPCa patients with cT4 tumor or with the shortest distance between the target and critical neural structures <0.8 cm were suboptimal candidates for IMPT adaptive re-planning. These criteria may improve resource utilization and clinical outcomes.

oncology
Review of "Impact of Trainees on Length of Stay in the Emergency Department at an Academic Medical Center" by Dehon E, McLemore G, McKenzie LK in South Med J 108: 245-248, 2015.

S. Clark,L. Hollier

DOI: https://doi.org/10.1097/SCS.0000000000002061

Abstract:
Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series.

Shaojun Lin,Jianji Pan,Lu Han,Xiuchun Zhang,Xiyi Liao,Jiade J Lu

DOI: https://doi.org/10.1016/j.ijrobp.2008.12.015

IF: 8.013

2009-01-01

International Journal of Radiation Oncology*Biology*Physics

Abstract:To evaluate the efficacy of intensity-modulated radiotherapy (IMRT) using reduced clinical target volumes (CTV) in the treatment of nasopharyngeal carcinoma (NPC).Between August 2003 and December 2006, 323 patients with NPC were treated with IMRT according to this institutional protocol. Presenting stages were Stage II in 63, Stage III in 166, and Stage IVA/B in 94 patients. High-risk CTV encompassed gross tumor volume and entire nasopharyngeal mucosa with a margin. A reduced CTV was delineated for the remaining subclinical regions adjacent to the primary disease. Uninvolved neck nodes were delineated according to the Radiation Therapy Oncology Group (RTOG)/European Organisation for Research and Treatment of Cancer (EORTC) consensus excluding the deep jugular (i.e., lymph nodes in retrostyloid space above C1 vertebra) and submental nodes. Patients with locoregionally advanced diseases also received cisplatin-based chemotherapy.With a median follow-up of 30 months (range, 4-53 months), 12, 6, and 26 patients had developed local, regional, and distant failures, respectively. The 3-year estimated local control, regional control, metastasis-free survival, disease-free survival and overall survival were 95%, 98%, 90%, 85%, and 90%, respectively. Multivariate analyses revealed that T-classification had no predictive value for outcome, whereas N-classification was significant for predicting metastasis-free (p = 0.005) and overall survival (p =0.006). Ten patients (7.8%) experienced Grade II xerostomia at 24 months after treatment. No Grade III or IV late-toxicities were observed. Two patients died of treatment-induced complications.The IMRT approach using a reduced target volume provided favorable outcome for NPC with acceptable toxicity. This strategy needs to be optimized and then tested in a prospective setting to learn whether further improvement can be achieved.
Changes of the Transverse Diameter and Volume and Dosimetry Before the 25th Fraction During the Course of Intensity-Modulated Radiation Therapy (imrt) for Patients with Nasopharyngeal Carcinoma

Haihua Yang,Wei Hu,Weijun Ding,Guoping Shan,Wei Wang,Changhui Yu,Biyun Wang,Minghai Shao,Jianhua Wang,Weifang Yang

DOI: https://doi.org/10.1016/j.meddos.2011.08.003

IF: 1.531

2012-01-01

Medical Dosimetry

Abstract:To quantify changes of the transverse diameter and volume and dosimetry, and to illustrate the inferiority of non-replanning during intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma (NPC) patients. Fifty-three NPC patients who received IMRT in 33 fractions were enrolled in this prospective trial. Before the 25th fraction, a new simulation computed tomography (CT) scan was acquired for all patients. The dose-volume histograms of the phantom plan were compared with the initial plan. Significant reduction of the transverse diameter of the nasopharyngeal, the neck, and 2 parotid glands volume was observed on second CT compared with the first CT (mean reduction 7.48 ± 4.45 mm, 6.80 ± 15.14 mm, 5.70 ± 6.26 mL, and 5.04 ± 5.85 mL, respectively; p < 0.01). The maximum dose and V-40 of the spinal cord, mean dose, and V30 of the left and right parotid, and V-50 of the brain stem were increased significantly in the phantom plan compared with the initial plan (mean increase 4.75 ± 5.55 Gy, 7.18 ± 10.07%, 4.51 ± 8.55 Gy, 6.59 ± 17.82%, 5.33 ± 8.55 Gy, 11.68 ± 17.11% and 1.48 ± 3.67%, respectively; p < 0.01). On the basis of dose constraint criterion in the RTOG0225 protocol, the dose of the normal critical structures for 52.83% (28/53) of the phantom plans were out of limit compared with 1.89% (1/53) of the initial plans (p < 0.0001). Because of the significant change in anatomy and dose before the 25th fraction during IMRT, replanning should be necessary during IMRT with NPC.
Anatomic and Dosimetric Changes During the Treatment Course of Intensity-Modulated Radiotherapy for Locally Advanced Nasopharyngeal Carcinoma

Xin Wang,Jiade Lu,Xiaopeng Xiong,Guopei Zhu,Hongmei Ying,Shaoqin He,Weigang Hu,Chaosu Hu

DOI: https://doi.org/10.1016/j.meddos.2009.06.007

IF: 1.531

2010-01-01

Medical Dosimetry

Abstract:Many patients with nasopharyngeal carcinoma (NPC) have marked anatomic change during intensity-modulated radiation therapy (IMRT). In this study, the magnitude of anatomic changes and its dosimetric effects were quantified. Fifteen patients with locally advanced NPC treated with IMRT had repeated computed tomography (CT) after 18 fractions. A hybrid plan was made to the anatomy of the second computed tomography scan. The dose of the original plan, hybrid plan, and new plan were compared. The mean volume of left and right parotid decreased 6.19 mL and 6.44 mL, respectively. The transverse diameters of the upper bound of odontoid process, the center of odontoid process, and the center of C2 vertebral body slices contracted with the mean contraction of 8.2 mm, 9.4 mm, and 7.6 mm. Comparing the hybrid plan with the treatment plan, the coverage of target was maintained while the maximum dose to the brain stem and spinal cord increased by 0.08 to 6.51 Gy and 0.05 to 7.8 Gy. The mean dose to left and right parotid increased by 2.97 Gy and 2.57 Gy, respectively. A new plan reduced the dose of spinal cord, brain stem, and parotids. Measurable anatomic changes occurring during the IMRT for locally advanced NPC maintained the coverage of targets but increased the dose to critical organs. Those patients might benefit from replanning.
[Dosimetric Verification and Clinical Efficacy of Intensity Modulated Radiotherapy in Nasopharyngeal Carcinoma].

Yingying Zhang,Juan Lin,Weibing Zhou,Jingtian Tang,Yuping Liao

DOI: https://doi.org/10.3321/j.issn:1672-7347.2009.09.008

2009-01-01

Abstract:OBJECTIVE To investigate dosimetric characteristics and to evaluate the clinical efficacy of intensity modulated radiotherapy (IMRT) as compared with conventional radiotherapy in nasopharyngeal carcinoma (NPC). METHODS Forty-seven NPC patients who accepted IMRT served as the IMRT group, and conventional radiotherapy plan was also made for each patient in this group using the treatment planning system. Dosiological evaluation of the 2 radiotherapy plans was made through dose volume histogram, 95% target volume dose (V(95)) and normal tissue complication probability. Another 47 patients who underwent conventional radiotherapy (CRT) at the same period formed the control group. The therapeutic effect as well as the acutes and late toxicities of normal tissues in the 2 groups were observed. RESULTS V(95) of the IMRT was more than 96% (96.83%-99.99%) for each target area, obviously superior to CRT in the sub-clinical target area. The radiation dose of normal tissues such as the brainstem and the spinal cord in the IMRT was much less than that in the CRT. Consistant with this, the part and complete remission rate, the 3-year loco-regional progress free survival rate, and overall survival rate in the IMRT group were all higher than those in the CRT group. For most patients in the IMRT group, the grade of acute toxicities was much lower than that in the CRT group. Patients in the IMRT group showed no more than grade 3 xerostomia, while in the CRT group still 21% of the patients suffered grade 3 or higher xerostomia a year later. CONCLUSION Compared with CRT, IMRT can improve the target volume dose and decrease the dose of surrounding tissues, resulting in higher control rate and fewer side effects.
Effects of minimum monitor unit per dynamic control point on intensity-modulated radiotherapy planning for nasopharyngeal carcinoma: A retrospective study

Xiwei Chen,Yuan Cheng,Weiwei Wu,Yadi He,Yangming Zhang,Liwan Han,Gaokui He,Zhenghuan Li

DOI: https://doi.org/10.1016/j.meddos.2024.09.003

2024-10-15

Abstract:The present study aimed to improve the dose distribution of radiotherapy planning for nasopharyngeal carcinoma (NPC) by comparing the effects of various minimum monitor units (MUs) per dynamic control point (MMCP) values on the quality and execution efficiency of dynamic intensity-modulated radiotherapy (IMRT) planning. Thirty-four clinically implemented dynamic IMRT plans for patients with NPC were retrospectively selected. In total, 170 plans were obtained by modifying only the MMCP values (set as 1, 3, 5, 7, and 9) in the treatment planning system's (TPS) optimization parameters. These plans were divided into 5 groups. Analyzing the effects of MMCP on the target and organ dose at risk (OAR), also the execution efficiency of the treatment plan in each group and using a quality score system, we conducted an objective quantitative study of the dose distribution and execution efficiency. The target dose evaluation indicators (target coverage (TC), homogeneity index (HI), and conformity index (CI)) of all IMRT plans showed a trend of variation with an increase in MMCP values, and the difference was statistically significant when MMCP values were 5, 7, 9, and 1 (p < 0.05). With an increase in MMCP, the dose to OAR slightly increased, but the difference was not statistically significant (p > 0.05). With an increase in MMCP, the average number of MUs per segment significantly increased (p < 0.01). The groups based on MMCP values of 1, 3, 5, 7, and 9 received quality score system of 1.188, 1.180, 1.171, 0.987, and 1.184, respectively, with the MMCP7 group achieving the lowest score, indicating that this plan had the highest overall quality. The MMCP value for dynamic IMRT planning in the Monaco TPS for patients with NPC should be set to 7 to achieve fewer segments, the best execution efficiency without significantly deteriorating the target and OAR dose.
Longitudinal Assessment of Quality of Life in Nasopharyngeal Cancer Patients Treated with Intensity-Modulated Proton Therapy and Volumetric Modulated Arc Therapy at Different Time Points

Kuan-Cho Liao,Yu-Jie Huang,Wen-Ling Tsai,Chien-Hung Lee,Fu-Min Fang

DOI: https://doi.org/10.3390/cancers16061217

2024-03-20

Cancers

Abstract:Purpose: This retrospective cohort study aims to compare the quality of life (QoL) in patients with nasopharyngeal cancer (NPC) treated with intensity-modulated proton therapy (IMPT) versus volumetric modulated arc therapy (VMAT) at different time points. Materials and Methods: We conducted a longitudinal assessment of QoL on 287 newly diagnosed NPC patients (IMPT: 41 and VMAT: 246). We collected outcomes of global QoL, functional QoL, C30 symptoms, and HN35 symptoms from EORTC QLQ-C30 and QLQ-HN35 questionnaires at pre-radiotherapy, during radiotherapy (around 40 Gy), 3 months post radiotherapy, and 12-months post radiotherapy (RT). The generalized estimating equation was utilized to interpret the group effect, originating from inherent group differences; time effect, attributed to RT effects over time; and interaction of the group and time effect. Results: IMPT demonstrated superior mean dose reductions in 12 of the 16 organs at risk compared to VMAT, including a significant (>50%) reduction in the oral cavity and larynx. Both groups exhibited improved scores of global QoL, functional QoL, and C30 symptoms at 12 months post RT compared to the pre-RT status. Regarding global QoL and C30 symptoms, there was no interaction effect of group over time. In contrast, significant interaction effects were observed on functional QoL (p = 0.040) and HN35 symptoms (p = 0.004) during RT, where IMPT created an average of 7.5 points higher functional QoL and 10.7 points lower HN35 symptoms than VMAT. Conclusions: Compared to VMAT, dose reduction attributed to IMPT could translate into better functional QoL and HN35 symptoms, but the effect is time dependent and exclusively observed during the RT phase.

oncology
Prioritizing Sufficient Dose to Gross Tumor Volume over Normal Tissue Sparing in Intensity-Modulated Radiotherapy Treatment of T4 Nasopharyngeal Carcinoma.

Yanyan Chen,Quxia Zhang,Tianzhu Lu,Cairong Hu,Jingfeng Zong,Yun Xu,Wei Zheng,Lisha Chen,Senan Lin,Sufang Qiu,Luying Xu,Jianji Pan,Qiaojuan Guo,Shaojun Lin

DOI: https://doi.org/10.1002/hed.27315

2023-01-01

Head & Neck

Abstract:BACKGROUND:In intensity-modulated radiation therapy (IMRT) for nasopharyngeal carcinoma (NPC), priority is often given minimize dose to the critical organs at risk (OARs) to avoid potential morbid sequelae. However, in T4 NPC, dosimetric inadequacy enforced by dose constraints on OARs may significantly impact tumor control.METHODS:This was a single-institute cohort that patients diagnosed between July 2005 and December 2010 with T4 NPC treated with IMRT. All patients were re-classification according to the 7th-AJCC stage.RESULTS:Overall, the average doses such as Dmax , D1% , D2% and D1cc for various Central nervous system (CNS) OARs including brainstem, optic nerve, chiasm, temporal lobes and spinal cord were found to exceed published guidelines as RTOG0225. However, no clinical toxicities were seen during the follow-up period except for 13% patients with temporal lobe necrosis.CONCLUSION:Our retrospective review showed that its feasible to maximize gross tumor volume dose coverage while exceeding most CNS OAR constraint standards, with ideal local control and no obvious increase of craniocerebral toxicity.
Long-term results of phase II trial of reduced modified clinical target volume in low-risk nasopharyngeal carcinoma treated with intensity modulated radiotherapy

J. Miao,M. Di,Y. Cao,L. Wang,W. Xiao,M. Zhu,B. Chen,S. Huang,F. Han,X. Deng,Y. Xiang,M.L.K. Chua,X. Guo,C. Zhao

DOI: https://doi.org/10.1093/annonc/mdz252.033

IF: 51.769

2019-10-01

Annals of Oncology

Abstract:<span class="paragraphSection">BackgroundIntensity modulated radiation therapy (IMRT) is the standard of care for nasopharyngeal carcinoma (NPC). Part of the IMRT quality assurance process involves accurate target volume delineation, which is crucial for local control and survival. Current practice utilizes a uniform contouring method for clinical target volume (CTV) for all stages of NPC. Here, we conducted a single-arm phase 2 trial investigating the tumor control rates of reduced CTV margins and corresponding doses in low-risk, early-stage NPC.MethodsPatients with biopsy-proven stage I-IIb (6th UICC/AJCC) NPC were enrolled. All patients were treated with IMRT alone. Two CTVs (CTV1 [high risk] and CTV2 [low risk]) were outlined; CTV1 was defined by grossly identified tumour (on MRI or CT) plus 5-mm margin (3-mm posteriorly); CTV2 was CTV1 plus 5-mm margin (3-mm posteriorly). 60 Gy and 50–54 Gy in 30 fractions were prescribed to CTV1 and CTV2, respectively. Primary end-point was locoregional recurrence free survival (LRRFS).ResultsFrom May 2001 to August 2006, 103 patients were recruited; all patients completed IMRT as planned (time duration 39-61 days). At a median follow-up of 12.6 years, five patients developed locoregional failures; of which one was in-field, and four were regional recurrence (two in-field and two marginal). 10-year LRRFS, distant metastasis free survival (DMFS), disease specific survival (DSS) and overall survival (OS) were 95.0% and 94.1%, 94.0% and 91.1%, respectively. The most common grade 1-2 late toxicities included subcutaneous fibrosis (79.6%), hearing loss (53.4%) and skin dystrophy (43.2%); grade 3 included subcutaneous fibrosis (2.9%) and hearing loss (2.9%); and no grade 4 late toxicity.ConclusionsReduced CTV margins and corresponding doses results in optimal long-term tumour control, with minimal late adverse events.Clinical trial identificationNCT03839602.Legal entity responsible for the studyChong Zhao.FundingNational Natural Science Foundation of China [No. 81872469]; Science and Technology Project of Guangdong Province [No. 2014A020212433].DisclosureM.L.K. Chua: Honoraria (institution), Advisory / Consultancy: Janssen, Astellas, Varian, Ferring Singapore and AstraZeneca; Research grant / Funding (institution), Structured research agreement/Research funding - Ferring Singapore, GenomeDx Biosciences, Varian, MedLever.: Ferring Singapore, GenomeDx Biosciences, Varian, MedLever. All other authors have declared no conflicts of interest.</span>

oncology
Impact of Reducing Clinical Target Volume on Efficacy of Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma

PAN Jina-ji,HAN Lu,ZHANG Yu,LIN Shao-jun,CHEN Chuan-ben,BAI Peng-gang,ZHANG Xiu-chun,LU Jia-de

DOI: https://doi.org/10.3760/cma.j.issn.1004-4221.2010.04.001

2010-01-01

Abstract:Objective To evaluate the impact of reducing clinical target volume (CTV) on the efficacy of intensity modulated radiation therapy (IMRT) for nasopharyngeal carcinoma (NPC) . Methods Between August 2003 and March 2007, 380 NPC patients were treated with IMRT with reduced CTV.CTV1, defined as high risk region, included GTV +5 - 10 mm margin and the entire nasopharyngeal mucosa +5 mm submucosal volume; CTV2, designed for potentially involved regions, included the nasopharyngeal cavity (limited to the posterior part of nasal cavity only), maxillary sinus (limited to 5 mm anterior to the posterior nasal aperture and maxillary mucosa), pterygopalatine fossa, posterior ethmoid sinus,parapharyngeal space, skull base, anterior third of clivus and cervical vertebra, inferior spheniod sinus and cavernous sinus and internal group of retropharyngeal lymph nodal regions from the base of skull to cranial edge of the second cervical vertebra. The prescription dose was: GTV 66. 00 -69. 75 Gy/30 - 33 f, CTV1 60. 00 -66. 65 Gy,CTV2/CTVN 54. 0 -55.8 Gy. 308 patients with stage Ⅲ or Ⅳ diseases also received cisplatin-based neoadjuvant chemotherapy. Results The follow-up rate was 100%. 145 patients were followed-up to 3 years. The 3-year estimated local control, regional control, metastasis-free survival,disease-free survival and overall survival rates were 94. 9%, 97.4%, 86. 2%, 80. 9% and 89. 0%,respectively. Multivariate analysis revealed that N-classification was a significant prognostic factor for metastasis-free survival (x2 = 20. 80, P = 0. 001), N-classification (x2 = 18. 30, P = 0. 003) and age (x2 =7. 31, P =0. 004) were independent prognostic factors for overall survival. Grade 2 xerostomia was observed in 5.6% of the patients after two years of IMRT, no Grade 3 or 4 xerostomia was observed. Local, regional,and distant failures were developed in 4. 2%, 2. 6% and 12. 1% of the patients, respectively. Conclusions The IMRT approach with reduced CTV2 provids a favorable outcome for NPC with acceptable toxicities.
Clinical Study of the Necessity of Replanning Before the 25th Fraction During the Course of Intensity-Modulated Radiotherapy for Patients with Nasopharyngeal Carcinoma

We Wang,Haihua Yang,Wei Hu,Guoping Shan,Weijun Ding,Changhui Yu,Biyun Wang,Xufeng Wang,Qianyi Xu

DOI: https://doi.org/10.1016/j.ijrobp.2009.08.036

2010-01-01

Abstract:Purpose: To quantify the target and normal structures on dose distributing variations during intensity-modulated radiotherapy (IMRT) and to assess the value of replanning for nasopharyngeal carcinoma (NPC) patients.Methods and Materials: Twenty-eight NPC patients treated with IMRT were recruited. The IMRT was delivered in 33 fractions, to 70 to 76Gy, to the gross tumor volume (GTV). Before the 25th fraction of IMRT, a new simulation computed tomography (CT) scan was acquired for all patients. According to the dose constraint criterion in the Radiation Therapy Oncology Group (RTOG) 0225 protocol, the replanning was generated on the new simulation CT. With the Quality Assessment Center of a CORVUS 6.3 treatment planning system, a phantom plan was generated for each patient by applying the beam configurations of the initial plan to the anatomy of the new simulation CT. The dose volume histograms of the phantom plan were compared with the replanning.Results: The percentage of prescription dose delivered to the clinical target volume (CTV1) was significantly increased by 4.91% +/- 10.89%, whereas the maximum dose to the spinal cord, mean dose to the left parotid, and V30 to the right parotid were significantly decreased by 5.00 +/- 9.23Gy, 4.23 +/- 10.03Gy, and 11.47% +/- 18.89% respectively in the replanning, compared with the phantom plan (p < 0.05). Based on the dose constraint criterion in the RTOG0225 protocol, 50% of phantom plans (14/28) were out of limit for the dose to the normal critical structures, whereas no plan was out of limit in replanning (p < 0.001).Conclusion: Replanning for patients with NPC before the 25th fraction during IMRT helps to ensure adequate dose to the target volumes and safe doses to critical normal structures. (C) 2010 Elsevier Inc.
Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.

Lu Han,Shao-Jun Lin,Jian-Ji Pan,Chuan-Ben Chen,Yu Zhang,Xiu-Chun Zhang,Xi-Yi Liao,Qi-Song Chen

DOI: https://doi.org/10.5732/cjc.009.10332

2010-01-01

Chinese Journal of Cancer

Abstract:Radiotherapy is effective in treating nasopharyngeal carcinoma (NPC). This study evaluated the treatment efficacy, toxicity, and prognostic factors of intensity-modulated radiotherapy (IMRT) in the treatment NPC.Between September 2003 and September 2006, 305 patients with NPC were treated with IMRT in Fujian Provincial Cancer Hospital. IMRT was delivered as follows: gross tumor volume (GTV) received 66.0-69.8 Gy in 30-33 fractions, high-risk clinical target volume (CTV-1) received 60.0-66.65 Gy, low-risk clinical target volume (CTV-2) and clinical target volume of cervical lymph node regions (CTV-N) received 54.0-55.8 Gy. Patients with stages III or IV disease also received cisplatin-based chemotherapy. All patients were assessed for local-regional control, survival, and toxicity.With a median follow-up of 35 months (range, 5-61 months), there were 16, 8, and 39 patients who had developed local, regional, and distant recurrence, respectively. The 3-year rates of local control, regional control, metastasis-free survival, disease-free survival, and overall survival were 94.3%, 97.7%, 86.1%, 80.3%, and 89.1%, respectively. Multivariate analyses revealed that T-classification had no predictive value for local control and survival, whereas N-classification was a significant prognostic factor for overall survival (P < 0.001), metastasis-free survival (P < 0.001), and disease-free survival (P = 0.003). For stages III-IV disease, concurrent and adjuvant chemotherapy did not influence prognosis. The most severe acute toxicities included Grade III mucositis in 14 patients (4.6%), Grade III skin desquamation in 90 (29.5%), and Grades III-IV leucocytopenia in 20 (6.5%). There were 7% patients with Grade II xerostomia after 2 years of IMRT, no Grades 3 or 4 xerostomia was detected.IMRT provided favorable locoregional control and survival rates for patients with NPC, even in those with locally advanced disease. The acute and late toxicities were acceptable. N-classification was the main factor of prognosis. Further study is needed on chemotherapy for patients with NPC.

Pregabalin in neuropathic pain: a more "pharmaceutically elegant" gabapentin?

Intensity-modulated radiotherapy of nasopharyngeal carcinoma: a comparative treatment planning study of photons and protons

Dosimetric Evaluation of Hippocampus Sparing Intensity Modulated Radiation Therapy in Patients with Stage T1-T2 and Stage T3-T4 Nasopharyngeal Carcinoma

Dosimetric comparison of intensity modulated radiotherapy and intensity modulated proton therapy in the treatment of recurrent nasopharyngeal carcinoma

[Interhemispheric extracranial and intracranial tumor of parietal area (chondromyxoid fibroma) in a 13-year-old child with 7 years of follow-up].

Robust optimization incorporating weekly predicted anatomtical CTs in IMPT of nasopharyngeal cancer

Potential effect of robust and simple IMRT approach for left-sided breast cancer on cardiac mortality.

Aortocaval fistula associated with ruptured abdominal aortic aneurysm.

Dosimetric Comparison and Selection Criteria of Intensity-Modulated Proton Therapy and Intensity-Modulated Radiation Therapy for Adaptive Re-Plan in T3-4 Nasopharynx Cancer Patients

Review of "Impact of Trainees on Length of Stay in the Emergency Department at an Academic Medical Center" by Dehon E, McLemore G, McKenzie LK in South Med J 108: 245-248, 2015.

Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series.

Changes of the Transverse Diameter and Volume and Dosimetry Before the 25th Fraction During the Course of Intensity-Modulated Radiation Therapy (imrt) for Patients with Nasopharyngeal Carcinoma

Anatomic and Dosimetric Changes During the Treatment Course of Intensity-Modulated Radiotherapy for Locally Advanced Nasopharyngeal Carcinoma

[Dosimetric Verification and Clinical Efficacy of Intensity Modulated Radiotherapy in Nasopharyngeal Carcinoma].

Effects of minimum monitor unit per dynamic control point on intensity-modulated radiotherapy planning for nasopharyngeal carcinoma: A retrospective study

Longitudinal Assessment of Quality of Life in Nasopharyngeal Cancer Patients Treated with Intensity-Modulated Proton Therapy and Volumetric Modulated Arc Therapy at Different Time Points

Prioritizing Sufficient Dose to Gross Tumor Volume over Normal Tissue Sparing in Intensity-Modulated Radiotherapy Treatment of T4 Nasopharyngeal Carcinoma.

Long-term results of phase II trial of reduced modified clinical target volume in low-risk nasopharyngeal carcinoma treated with intensity modulated radiotherapy

Impact of Reducing Clinical Target Volume on Efficacy of Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma

Clinical Study of the Necessity of Replanning Before the 25th Fraction During the Course of Intensity-Modulated Radiotherapy for Patients with Nasopharyngeal Carcinoma

Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.